Subscribe To
Brickell biotech aces pivotal sofpironium trials in patients with excessive underarm sweating
Brickell Biotech Inc (NASDAQ: BBI) has announced positive topline results from the Phase 3 pivotal Cardigan I and Cardigan II studies of sofpironiu...
October 7, 2021, 9:05 am
Brickell biotech announces positive topline results, achieving statistical significance on all primary and secondary endpoints, from both u.s. phase 3 pivotal clinical studies of sofpironium bromide g
Sofpironium bromide gel, 15% was generally well-tolerated...
October 7, 2021, 6:55 am
Brickell biotech announces positive topline results, achieving statistical significance on all primary and secondary endpoints, from both u.s. phase 3 pivotal clinical studies of sofpironium bromide g
Sofpironium bromide gel, 15% was generally well-tolerated...
October 7, 2021, 6:55 am
Brickell biotech announces positive topline results, achieving statistical significance on all primary and secondary endpoints, from both u.s. phase 3 pivotal clinical studies of sofpironium bromide g
Sofpironium bromide gel, 15% was generally well-tolerated...
October 7, 2021, 6:55 am
Brickell biotech announces positive topline results, achieving statistical significance on all primary and secondary endpoints, from both u.s. phase 3 pivotal clinical studies of sofpironium bromide g
Sofpironium bromide gel, 15% was generally well-tolerated...
October 7, 2021, 6:55 am
Brickell biotech announces positive topline results, achieving statistical significance on all primary and secondary endpoints, from both u.s. phase 3 pivotal clinical studies of sofpironium bromide g
Sofpironium bromide gel, 15% was generally well-tolerated...
October 7, 2021, 6:55 am
Brickell biotech announces positive topline results, achieving statistical significance on all primary and secondary endpoints, from both u.s. phase 3 pivotal clinical studies of sofpironium bromide g
Sofpironium bromide gel, 15% was generally well-tolerated...
October 7, 2021, 6:55 am
Levi strauss ceo explains how the company has been able to pivot supply chains during covid
Following the release of the company's third-quarter results, Levi Strauss & Co. CEO and President Chip Bergh appeared on Wednesday's episode of "Mad ...
October 6, 2021, 7:43 pm
Levi strauss ceo explains how the company has been able to pivot supply chains during covid
Following the release of the company's third-quarter results, Levi Strauss & Co. CEO and President Chip Bergh appeared on Wednesday's episode of "Mad ...
October 6, 2021, 7:43 pm
Levi strauss ceo explains how the company has been able to pivot supply chains during covid
Following the release of the company's third-quarter results, Levi Strauss & Co. CEO and President Chip Bergh appeared on Wednesday's episode of "Mad ...
October 6, 2021, 7:43 pm
Avoid this blue-chip stock in october
Last month proved to be a pivotal one for the S&P 500 Index (SPX), as " September seasonality " resulted in a monthly losses for the index, which also...
October 6, 2021, 2:57 pm
Avoid this blue-chip stock in october
Last month proved to be a pivotal one for the S&P 500 Index (SPX), as " September seasonality " resulted in a monthly losses for the index, which also...
October 6, 2021, 2:57 pm
Avoid this blue-chip stock in october
Last month proved to be a pivotal one for the S&P 500 Index (SPX), as " September seasonality " resulted in a monthly losses for the index, which also...
October 6, 2021, 2:57 pm
An unexpected pivot to esg makes naked brand stock more interesting—and viable
NAKD stock holders have been waiting for ages to see the share price surpass $1 and stay there. A fresh CEO announcement could get it done....
October 5, 2021, 1:22 pm
An unexpected pivot to esg makes naked brand stock more interesting—and viable
NAKD stock holders have been waiting for ages to see the share price surpass $1 and stay there. A fresh CEO announcement could get it done....
October 5, 2021, 1:22 pm
An unexpected pivot to esg makes naked brand stock more interesting—and viable
NAKD stock holders have been waiting for ages to see the share price surpass $1 and stay there. A fresh CEO announcement could get it done....
October 5, 2021, 1:22 pm
An unexpected pivot to esg makes naked brand stock more interesting—and viable
NAKD stock holders have been waiting for ages to see the share price surpass $1 and stay there. A fresh CEO announcement could get it done....
October 5, 2021, 1:22 pm
An unexpected pivot to esg makes naked brand stock more interesting—and viable
NAKD stock holders have been waiting for ages to see the share price surpass $1 and stay there. A fresh CEO announcement could get it done....
October 5, 2021, 1:22 pm
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am